Long-term persistence of HIV-1 vaccine-induced CD4 +CD45RA -CD62L -CCR7 - memory T-helper cells

AIDS

Volumn 18, Issue 6, 2004, Pages 837-848

  Balla Jhagjhoorsingh, Sunita S ^a   Koopman, Gerrit ^a   Mooij, Petra ^a   Koornstra, Wim ^a   McCormack, Sheena ^b   Weber, Jonathan ^c   Pantaleo, Giuseppe ^d   Heeney, Jonathan L ^a  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^b Med Res Cncl Clinical Trials Unit   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

CD4 T helper cells; HIV; Memory; Primate; Vaccines

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; GLYCOPROTEIN D; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 2; INTERLEUKIN 4; PADGEM PROTEIN; PHOSPHORYL LIPID A; SAPONIN; VIRUS ENVELOPE PROTEIN;

ADOLESCENT; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CHIMPANZEE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPITOPE MAPPING; HELPER CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MEMORY CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

AIDS VACCINES; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, CD45; CYTOKINES; EPITOPES; HIV-1; IMMUNOLOGIC MEMORY; L-SELECTIN; PAN TROGLODYTES; RECEPTORS, CHEMOKINE; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; TIME FACTORS;

EID: 2142768792     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200404090-00001     Document Type: Article

References (43)

1. Heeney JL. The critical role of CD4(+) T-cell help in immunity to HIV. Vaccine 2002; 20:1961-1963.
2. Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 1997; 278: 1447-1450.
3. Koopman G, Niphuis H, Newman W, Kishimoto TK, Maino VC, Heeney JL. Decreased expresson of IL-2 in central and effector CD4 memory cells during expression to AIDS in rhesus macaques. AIDS 2001; 15:1-11.
4. Mooij P, Heeney JL. Rational development of prophylactic HIV vaccines based on structural and regulatory proteins. Vaccine 2001; 20:304-321.
5. Heeney JL, Beverley P, McMichael A, Shearer G, Strominger J, Wahren B, et al. Immune correlates of protection from HIV and AIDS - more answers but yet more questions. Immunol Today 1999; 20:247-251.
6. Stoute JA, Slaoui M, Heppner DG, Momin P, Kester KE, Desmons P, et al. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group [see comments]. N Engl J Med 1997; 336:86-91.
7. Voss G, Villinger F. Adjuvanted vaccine strategies and live vector approaches for the prevention of AIDS. AIDS 2000; 14: S153-165.
8. Mooij P, van der Kolk M, Bogers WM, ten Haaft PJ, Van Der Meide P, Almond N, et al. A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian-human immunodeficiency virus infection. AIDS 1998; 12:F15-22.
9. Balla-Jhagjhoorsingh S, Mooij P, Koopman G, Haaksma T, Teeuwsen V, Heeney J, et al. Differential cytotoxic T-lymphocyte (CTL) responses in HIV-1 immunised sibling chimpanzees with shared MHC haplotypes. Immunol Lett 1999; 66:61-67.
10. Jones GJ, von Hoegen P, Weber J, Rees AD. Immunization with human immunodeficiency virus type 1 rgp120W61D in QS21/ MPL adjuvant primes T cell proliferation and C-C chemokine production to multiple epitopes within variable and conserved domains of gp120W61D. J Infect Dis 1999; 179:558-566.
11. McCormack S, Tilzey A, Carmichael A, Gotch F, Kepple J, Newberry A, et al. A phase I trial in HIV negative healthy volunteers evaluating the effect of potent adjuvants on immunogenicity of a recombinant gp120W61D derived from dual tropic R5X4 HIV-1ACH320. Vaccine 2000; 18:1166-1177.
12. Schluns KS, Lefrancois L. Cytokine control of memory T-cell development and survival. Nat Rev Immunol 2003; 3:269-279.
13. Klein J, Blancher A. Molecular biology & evolution of blood group & MHC antigens in primates. 1997.
14. Weninger W, Crowley MA, Manjunath N, von Andrian UH. Migratory properties of naive, effector, and memory CD8(+) T cells. J Exp Med 2001; 194:953-966.
15. Garcia S, DiSanto J, Stockinger B. Following the development of a CD4 T cell response in vivo: from activation to memory formation. Immunity 1999; 11:163-171.
16. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. T cell receptor antagonist peptides induce positive selection. Cell 1994; 76:17-27.
17. Homann D, Teyton L, Oldstone MB. Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat Med 2001; 7:913-919.
18. Groenink M, Fouchier RA, de Goede RE, de Wolf F, Gruters RA, Cuypers HT, et al. Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type 1 clones derived from a single individual. J Virol 1991; 65:1968-1975.
19. de Groot NG, Otting N, Arguello R, Watkins DI, Doxiadis GG, Madrigal JA, et al. Major histocompatibility complex class I diversity in a West African chimpanzee population: implications for HIV research. Immunogenetics 2000; 51:398-409.
20. Balla-Jhagjhoorsingh SS, Mooij P, ten Haaft PJ, Bogers WM, Teeuwsen VJ, Koopman G, et al. Protection from secondary human immunodeficiency virus type 1 infection in chimpanzees suggests the importance of antigenic boosting and a possible role for cytotoxic T cells. J Infect Dis 2001; 184:2.
21. van der Meide PH, Groenestein RJ, de Labie MC, Heeney J, Pala P, Slaoui M. Enumeration of lymphokine-secreting cells as a quantitative measure for cellular immune responses in rhesus macaques. J Med Primatol 1995; 24:271-281.
22. Heeney JL, van Els C, de Vries P, ten Haaft P, Otting N, Koornstra W, et al. Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells. J Exp Med 1994; 180:769-774.
23. Balla-Jhagjhoorsingh SS, Koopman G, Mooij P, Haaksma TG, Teeuwsen VJ, Bontrop RE, et al. Conserved CTL epitopes shared between HIV-infected human long-term survivors and chimpanzees. J Immunol 1999; 162:2308-2314.
24. Cecilia D, KewalRamani VN, O'Leary J, Volsky B, Nyambi P, Burda S, et al. Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage. J Virol 1998; 72:6988-6996.
25. Trkola A, Ketas T, Kewalramani VN, Endorf F, Binley JM, Katinger H, et al. Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage. J Virol 1998; 72:1876-1885.
26. Jung T, Schauer U, Heusser C, Neumann C, Rieger C. Detection of intracellular cytokines by flow cytometry. J Immunol Methods 1993; 159:197-207.
27. van Essen D, Dullforce P, Brocker T, Gray D. Cellular interactions involved in Th cell memory. J Immunol 2000; 165:3640-3646.
28. Bogers WM, Koornstra WH, Dubbes RH, ten Haaft PJ, Verstrepen BE, Jhagjhoorsingh SS, et al. Characteristics of primary infection of a European human immunodeficiency virus type 1 clade B isolate in chimpanzees. J Gen Virol 1998; 79:2895-2903.
29. Manca F, Seravalli E, Valle MT, Fenoglio D, Kunkl A, Li Pira G, et al. Non-covalent complexes of HIV gp120 with CD4 and/or mAbs enhance activation of gp120-specific T clones and provide intermolecular help for anti-CD4 antibody production. Int Immunol 1993; 5:1109-1117.
30. Ahmed R, Gray D. Immunological memory and protective immunity: understanding their relation. Science 1996; 272: 54-60.
31. Zinkernagel RM, Bachmann MF, Kundig TM, Oehen S, Pirchet H, Hengartner H. On Immunological memory. Annu Rev Immunol 1996; 14:333-367.
32. Dutton RW, Bradley LM, Swain SL. T cell memory. Annu Rev Immunol 1998; 16:201-223.
33. Mackay CR. Homing of naive, memory and effector lymphocytes. Curr Opin Immunol 1993; 5:423-427.
34. MacLennan IC, Gulbranson-Judge A, Toellner KM, Casamayor-Palleja M, Chan E, Sze DM, et al. The changing preference of T and B cells for partners as T-dependent antibody responses develop. Immunol Rev 1997; 156:53-66.
35. Gunn MD, Tangemann K, Tam C, Cyster JG, Rosen SD, Williams LT. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci USA 1998; 95:258-263.
36. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401:708-712.
37. Champagne P, Ogg GS, King AS, Knabenhans C, Ellefsen K, Nobile M, et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001; 410:106-111.
38. Lalvani A, Moris P, Voss G, Pathan AA, Kester KE, Brookes R, et al. Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine. J Infect Dis 1999, 180:1656-1664.
39. Fearon DT, Manders P, Wagner SD. Arrested differentiation, the self-renewing memory lymphocyte, and vaccination. Science 2001; 293:248-250.
40. Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 2000; 18:593-620.
41. Masopust D, Vezys V, Marzo AL, Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001; 291:2413-2417.
42. Reinhardt RL, Khoruts A, Merica R, Zell T, Jenkins MK. Visualizing the generation of memory CD4 T cells in the whole body. Nature 2001; 410:101-105.
43. Sprent J, Tough DF. T cell death and memory. Science 2001; 293:245-248.